Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
As of today, Eli Lilly(LLY) shares are valued at $1,174.18. The company's market cap stands at 1.11T, with a P/E ratio of 42.09 and a dividend yield of 0.55%.
During the trading session on 2026-07-21, Eli Lilly(LLY) shares reached a daily high of $1,175.20 and a low of $1,135.00. At a current price of $1,174.18, the stock is +3.5% higher than the low and still -0.1% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 1.31M, versus its average volume of 2.51M.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.
LLY News
...
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. Fo...
A spokesperson for Eli Lilly (LLY) told Bloomberg that the company’s weight loss drug ads are “truthful” and “transparent,” adding that the company will defend...
Analyst ratings
81%
of 31 ratingsMore LLY News
Novo Nordisk (NVO) has filed a lawsuit against rival pharmaceutical company Eli Lilly (LLY), claiming that advertising campaigns for its weight-loss drugs are d...
The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo? 7/16/2026 FDA advisors will debate the merits of seven peptides next week. The disc...
The legal clash between Novo Nordisk and Eli Lilly over GLP-1 drug advertising puts a spotlight on how powerful marketing claims can be in shaping demand for ob...
Ozempic maker Novo Nordisk has filed a lawsuit against Eli Lilly, arguing it uses deceptive advertising to mislead consumers. The complaint accuses Eli Lilly o...
Novo Nordisk says it sent its rival a cease-and-desist letter in April. Mads Claus Rasmussen / AFP / Getty Images Novo Nordisk NOVO.B -1.68 %decrease; down poi...
Novo Nordisk (NVO) said in U.S. federal court that it is suing Eli Lilly (LLY), claiming that its competitor’s advertising for its obesity shot Zepbound and dia...
Key Points Novo Nordisk filed a lawsuit against Eli Lilly, alleging that its advertising campaigns for its blockbuster obesity and diabetes drugs are designed t...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.